|
π
|
Triplet Therapy, Transplantation, and Maintenance until Progression in Myeloma.
56 auth.
P. Richardson,
S. Jacobus,
E. Weller,
H. Hassoun,
S. Lonial,
N. Raje,
E. Medvedova,
P. McCarthy,
E. Libby,
P. Voorhees,
R. Orlowski,
L. Anderson,
J. Zonder,
C. Milner,
C. Gasparetto,
...
M. Agha,
A. Khan,
D. Hurd,
K. Gowin,
R. Kamble,
S. Jagannath,
N. Nathwani,
M. Alsina,
R. Cornell,
Hamza Hashmi,
E. Campagnaro,
Astrid C. M. Andreescu,
T. Gentile,
M. Liedtke,
Kelly Godby,
A. Cohen,
T. Openshaw,
M. Pasquini,
S. Giralt,
J. Kaufman,
A. Yee,
E. Scott,
P. Torka,
A. Foley,
M. Fulciniti,
K. Hebert,
M. Samur,
Kelly Masone,
Michelle E. Maglio,
Andrea A. Zeytoonjian,
Omar Nadeem,
R. Schlossman,
J. Laubach,
Claudia E. Paba-Prada,
I. Ghobrial,
A. Perrot,
P. Moreau,
H. Avet-Loiseau,
M. Attal,
K. Anderson,
N. Munshi
|
7 |
2022 |
7
π
|
|
π
|
Ruxolitinib in adult patients with secondary haemophagocytic lymphohistiocytosis: an open-label, single-centre, pilot trial.
15 auth.
Asra Z. Ahmed,
Samuel A Merrill,
F. Alsawah,
P. Bockenstedt,
E. Campagnaro,
S. Devata,
S. Gitlin,
M. Kaminski,
Alice Cusick,
T. Phillips,
...
S. Sood,
M. Talpaz,
A. Quiery,
P. Boonstra,
R. Wilcox
|
7 |
2019 |
7
π
|
|
π¬
|
EGFR enhances early healing after cutaneous incisional wounding.
S. Repertinger,
E. Campagnaro,
Jill Fuhrman,
T. El-Abaseri,
S. Yuspa,
L. Hansen
|
7 |
2004 |
7
π¬
|
|
π
|
Multiple Myeloma, Version 3.2021, NCCN Clinical Practice Guidelines in Oncology.
29 auth.
Shaji K. Kumar,
N. Callander,
K. Adekola,
L. Anderson,
M. Baljevic,
E. Campagnaro,
J. Castillo,
J. Chandler,
C. Costello,
Y. Efebera,
M. Faiman,
Alfred L. Garfall,
Kelly Godby,
J. Hillengass,
L. Holmberg,
...
M. Htut,
C. Huff,
Yubin Kang,
M. Hultcrantz,
Sarah M. Larson,
M. Liedtke,
T. Martin,
J. Omel,
K. Shain,
D. Sborov,
K. Stockerl-Goldstein,
D. Weber,
J. Keller,
Rashmi Kumar
|
7 |
2020 |
7
π
|
|
π
|
NCCN Guidelines Insights: Multiple Myeloma, Version 1.2020.
31 auth.
Shaji K. Kumar,
N. Callander,
J. Hillengass,
M. Liedtke,
M. Baljevic,
E. Campagnaro,
J. Castillo,
J. Chandler,
R. Cornell,
C. Costello,
Y. Efebera,
M. Faiman,
Alfred L. Garfall,
Kelly Godby,
L. Holmberg,
...
M. Htut,
C. Huff,
Yubin Kang,
O. Landgren,
E. Malek,
T. Martin,
J. Omel,
N. Raje,
D. Sborov,
S. Singhal,
K. Stockerl-Goldstein,
C. Tan,
D. Weber,
Alyse Johnson-Chilla,
J. Keller,
Rashmi Kumar
|
7 |
2019 |
7
π
|
|
π
|
Genomic profiling identifies alterations in TGFΞ² signaling through loss of TGFΞ² receptor expression in human renal cell carcinogenesis and progression
9 auth.
J. Copland,
B. Luxon,
Laila Ajani,
Tapati Maity,
E. Campagnaro,
Huiping Guo,
...
Shauna N. LeGrand,
P. Tamboli,
C. Wood
|
6 |
2003 |
6
π
|
|
π
|
Phase II trial of combination therapy with bortezomib, pegylated liposomal doxorubicin, and dexamethasone in patients with newly diagnosed myeloma.
11 auth.
A. Jakubowiak,
T. Kendall,
A. Al-Zoubi,
Y. Khaled,
S. Mineishi,
Asra Z. Ahmed,
...
E. Campagnaro,
C. Brozo,
T. Braun,
M. Talpaz,
M. Kaminski
|
6 |
2009 |
6
π
|
|
π
|
Lenalidomide, bortezomib, pegylated liposomal doxorubicin, and dexamethasone in newly diagnosed multiple myeloma: a phase 1/2 Multiple Myeloma Research Consortium trial.
21 auth.
A. Jakubowiak,
K. Griffith,
D. Reece,
C. Hofmeister,
S. Lonial,
T. Zimmerman,
E. Campagnaro,
R. Schlossman,
J. Laubach,
N. Raje,
...
Tara B. Anderson,
M. Mietzel,
Colleen K. Harvey,
Sandra Wear,
Jennifer Barrickman,
C. Tendler,
D. Esseltine,
S. Kelley,
M. Kaminski,
K. Anderson,
P. Richardson
|
6 |
2011 |
6
π
|
|
π¦
|
Symptom burden after autologous stem cell transplantation for multiple myeloma
10 auth.
E. Campagnaro,
R. Saliba,
S. Giralt,
L. Roden,
F. Mendoza,
A. AlemΓ‘n,
...
C. Cleeland,
D. Weber,
Jane Brown,
K. Anderson
|
5 |
2008 |
5
π¦
|
|
π
|
A Pathobiological Role of the Insulin Receptor in Chronic Lymphocytic Leukemia
11 auth.
Kamlai Saiya-Cork,
R. Collins,
B. Parkin,
P. Ouillette,
Erlene Kuizon,
Lisa A Kujawski,
...
H. Erba,
E. Campagnaro,
K. Shedden,
M. Kaminski,
S. Malek
|
5 |
2011 |
5
π
|
